| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.6M | — | +127.3% |
| Cost of Revenue | $219K | — | +11.2% |
| R&D Expense | $29.2M | — | -19.3% |
| SG&A Expense | $20.1M | — | +84.0% |
| Operating Income | -$45.7M | — | -16.2% |
| Pre-tax Income | -$53.0M | — | -23.0% |
| Income Tax | $488K | — | -1.6% |
| Net Income | -$53.5M | — | -22.7% |
| EPS (Basic) | -$0.85 | — | -3.7% |
| EPS (Diluted) | -$0.85 | — | -3.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $140.0M | +74.5% | -35.6% |
| Accounts Receivable | $3.6M | -39.2% | — |
| Current Assets | $615.7M | -6.1% | +41.4% |
| Total Assets | $778.7M | -5.6% | +28.6% |
| Current Liabilities | $59.2M | -5.9% | +63.0% |
| Long-term Debt | $49.9M | -30.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$38.2M | — | +13.3% |
| Capital Expenditures | $140K | — | +11.1% |
| Investing Cash Flow | $98.6M | — | +390.4% |
| Financing Cash Flow | $550K | — | -99.3% |
| Free Cash Flow | -$38.4M | — | +13.2% |
| -3.2% |
| Total Liabilities | $629.4M | +0.5% | +10.1% |
| Stockholders' Equity | $149.3M | -24.9% | +343.3% |